Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) significantly impacts women's emotional well-being and social lives, requiring treatments that include psychological support.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Using psychological treatments can help manage skin conditions along with regular medical care.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Human sexuality involves complex mental processes unique to humans.

The document concludes that pediatricians play a vital role in supporting adolescents through puberty and should enhance their competence in this area.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

DSDs are birth conditions causing unusual sex development, managed with personalized care and sometimes surgery, but still lack a standard treatment approach.

SSRI antidepressants can cause long-lasting sexual problems.

Many different biological, psychological, and social factors can cause sexual dysfunction in American women.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Telemedicine is effective for sexual medicine consultations.

Most genital symptoms in prepubertal girls are normal or nontraumatic, not signs of abuse.